7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology

美国动脉硬化、血栓和血管生物学(ATVB)理事会春季年会 美国心脏协会与营养、体力活动和新陈代谢(NPAM)一起召开 AHA理事会。这次会议的目的是将致力于基础和高级研究的初级和高级科学家聚集在一起 心血管疾病的临床方面，目的是促进科学交流，以便 促进更快地吸收新知识。通过涵盖的许多学科， ATVB和NPAM理事会，这次会议具有更广泛的吸引力，有可能提供交流和 以其他方式无法获得的见解。会议的设计计划是为了鼓励 互动和讨论是这次会议的一个重要组成部分，具有教育意义。会议的规模是 足够小，以允许学生和研究员一起积极参与海报和口头会议 来自多个学科的国内和国际知名科学家。总的来说，该计划的具体目标 会议的目的是：1)促进科学信息和实验战略的交流 在与心血管疾病相关的不同领域工作的调查人员；2)识别和传播 关于可促进所有领域研究的新技术的信息；3)加强 将基础科学成果转化为转化性/临床前研究，并最终应用于临床；4)提供 学生和研究员的论坛，向有鉴别力的观众展示数据，着眼于鼓励 他们在实地的发展和保留；以及5)鼓励相关领域的调查人员成为 认识并促进他们之间的科学合作。自那以后，这个会议每年举行一次。 2000年，出席人数约为800人，其中包括约500名个人讲演。 大小保持不变，甚至随着时间的推移而增加的趋势被视为继续 会议一定会成功。

The annual Spring meeting of the Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) Council of the American Heart Association is held together with the Nutrition, Physical Activity, and Metabolism (NPAM) Council of AHA. The meeting is intended to bring together junior and senior scientists working on basic and clinical aspects of cardiovascular disease for the purpose of advancing scientific interchange in order to facilitate a more rapid assimilation of new knowledge. By encompassing the many disciplines covered by the ATVB and NPAM councils, the meeting has a broader appeal that potentially provides interchanges and insights that would not otherwise become available. The design of the meeting is planned to encourage interaction and discussion and a key component of this meeting is educational. The size of the meeting is small enough to permit students and fellows to actively participate in poster and oral sessions together with well known national and international scientists from several disciplines. Overall, the specific aims of the conference are 1) to promote the exchange of scientific information and experimental strategies among investigators working in diverse areas pertinent to cardiovascular disease; 2) to identify and disseminate information about novel technologies that can advance research across all areas; 3) enhance the transfer of basic science findings into translational/preclinical studies and ultimately to clinical applications; 4) provide a forum for students and fellows to present data to a discriminating audience with an eye toward encouraging their development and retention in the field; and 5) to encourage investigators in related fields to become acquainted and to promote scientific collaborations among them. This meeting has been held annually since the year 2000, with attendance reaching about 800 participants including about 500 individual presentations. The trend for the size to remain constant and even increase with time is taken as a sign that continued success of the meeting is assured.